Caribou Biosciences's total assets for Q3 2024 were $344.33M, a decrease of -7.67% from the previous quarter. CRBU total liabilities were $63.13M for the fiscal quarter, a 1.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.